Sanofi, T1D Exchange to investigate optimal care for young people with diabetes
Sanofi, a global healthcare comapny, and T1D Exchange, a non-profit organization focused on type 1 diabetes, will collaborate on the TEENs registry study, which aims to provide the type 1 diabetes com…Sanofi and T1D Exchange to launch worldwide study
Sanofi (EURONEXT: SAN and NYSE: SNY) and T1D Exchange, a non-profit organization focused on type 1 diabetes, will collaborate on the TEENs registry study. The aim of the study is to provide the type 1…Aeras, GSK to jointly advance TB vaccine
Posted: October 10th, 2012 | Company/topic: GlaxoSmithKline
Website: CenterWatch News Online Headlines
Aeras, a fully-integrated tuberculosis (TB) vaccine development organization, has signed an agreement with global healthcare company GlaxoSmithKline to jointly advance the clinical development of an i…Website: CenterWatch News Online Headlines
Tags: development, glaxosmithkline, global healthcare company, organization, tb vaccine development, tuberculosis tb

